Polaris Partners

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With additional offices in San Francisco and New York, the firm specializes in investing across all stages of technology and healthcare companies, including life sciences and biotechnology. Polaris has established a strong track record over its more than 20 years in the industry, focusing on partnering with repeat entrepreneurs and innovators who are enhancing quality of life and work. The firm's investments are directed primarily within the United States and Europe, supporting companies from their founding stages to profitable growth.

William Allard

Venture Partner

Jonathan Ang

Entrepreneur Partner

Mark Augenstern

Associate

David Barrett

Managing Partner

David Barrett

Partner

Marissa Bertorelli

Principal

Mary Blair

CFO

Alexandra Cantley

Partner

Darren Carroll

Partner

Brian Chee

Managing Partner

Isaac Ciechanover

Partner

Alan Crane

Partner and Entrepreneur

Jon Flint

Founding Partner

Jonathan Flint

Founding Partner

Harold Friedman

CFO

John Gannon

CFO and Partner

Nil Gural

Senior Associate

Brendan Hannigan

Entrepreneur Partner

Rahul Kakkar

Entrepreneur Partner

Pat Kinsel

Partner

Scott Martin

Senior Associate

Eileen McGuire

Partner

Ellie McGuire

Partner

Terry McGuire

Founding Partner

Sabrina Chiasson

Principal

Pat Mulach

Senior Associate

Kim Png

Principal

Noel Ruane

Venture Partner

Jim Weinstein

Entrepreneur Partner

Past deals in Health Care

Nomad Health

Venture Round in 2022
Nomad Health, Inc. operates an online marketplace that connects healthcare professionals with freelance and permanent job opportunities in the United States. Founded in 2015 and based in New York, the platform allows doctors and nurses to search for positions by various criteria, including location and pay rate. By streamlining the healthcare staffing process, Nomad Health aims to simplify job searches for medical professionals and facilitate the hiring needs of healthcare facilities. This modern technology platform addresses the complexities of traditional healthcare staffing, promoting efficiency and accessibility in the job market.

Foresight Mental Health

Series C in 2022
Foresight Mental Health is a technology-enabled company focused on providing comprehensive psychiatry and therapy services. It employs a team of psychiatrists, therapists, and psychiatric nurse practitioners who deliver treatment directly to patients in its clinics. Foresight aims to transform mental healthcare by integrating advanced technology developed by its software and biomedical engineers with clinical practice. The company offers a wide range of mental health treatments and wellness services, utilizing patient profiles that incorporate scientific research, genetic information, and detailed assessments of symptoms and brain chemistry. This holistic approach is designed to enhance patient outcomes, promoting improved mental health and overall well-being.

Nomad Health

Series D in 2021
Nomad Health, Inc. operates an online marketplace that connects healthcare professionals with freelance and permanent job opportunities in the United States. Founded in 2015 and based in New York, the platform allows doctors and nurses to search for positions by various criteria, including location and pay rate. By streamlining the healthcare staffing process, Nomad Health aims to simplify job searches for medical professionals and facilitate the hiring needs of healthcare facilities. This modern technology platform addresses the complexities of traditional healthcare staffing, promoting efficiency and accessibility in the job market.

ByHeart

Series B in 2021
ByHeart, Inc. is an infant nutrition company that develops a range of nutritional food products for infants and babies, focusing on immune, microbiome, cognitive, and digestive health. Founded in 2016 and headquartered in New York, the company operates facilities in Pennsylvania. ByHeart emphasizes the use of hand-picked ingredients and small-batch blending to create formulas that reflect the latest in nutrition science and breastmilk research. Their products are designed to support babies' health and provide parents with peace of mind, offering choices that help establish a strong foundation for future well-being.

OM1

Series D in 2021
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Wellthy

Series B in 2021
Wellthy, Inc. is a family care concierge service based in New York, established in 2014. The company specializes in assisting individuals and families in managing the complexities of care for chronically ill, aging, or disabled loved ones. Wellthy connects families with dedicated Care Coordinators who help navigate the logistical and administrative tasks associated with caregiving. Their platform enables families to track appointments, organize tasks, store important documents, and maintain communication. Wellthy addresses various needs beyond medical care, including legal, financial, housing, and emotional support. The service is designed to alleviate the burden of caregiving by taking on tasks such as making calls, scheduling appointments, and managing paperwork. Additionally, Wellthy partners with employers to offer a compassionate and scalable solution to support families dealing with aging-related issues, childcare, special needs, and other ongoing care challenges.

Thirty Madison

Series C in 2021
Thirty Madison, Inc. is a digital health company based in Astoria, New York, focused on providing specialized care for chronic conditions through its web-based platforms. Founded in 2016, the company operates several condition-specific brands: Keeps, which offers a subscription service for men's hair loss prevention medications; Cove, which provides online consultations and prescriptions for migraine treatment; and Evens, designed to manage acid reflux. By offering these tailored services, Thirty Madison aims to increase access to affordable healthcare solutions, addressing the unique needs of patients suffering from these conditions.

Cohere Health

Series B in 2021
Cohere Health, Inc. is a software-as-a-service company based in Boston, Massachusetts, that focuses on enhancing the healthcare experience for patients, providers, and health plans. Incorporated in 2019, the company aims to improve the quality of care while reducing overall costs and increasing transparency throughout the patient care journey. Cohere Health specializes in intelligent prior authorization services, which are tailored to meet the specific needs of different health plans. By leveraging artificial intelligence, machine learning, and real-time analytics, the company automates the prior authorization process and facilitates collaboration between physicians and health plans. This approach not only streamlines the utilization management service but also promotes quality care across the entire patient journey.

Tausight

Series A in 2021
Tausight, Inc. develops a software for reducing healthcare cyber incidents of patient data theft. It serves chief information officer of health care sector. Tausight was founded in 2018 and is based in Sudbury, Massachusetts with additional office in San Francisco, California.

FOLX

Series A in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Covetrus

Seed Round in 2021
Developer of veterinary practice management software intended to empower veterinary practice partners to drive improved health and financial outcomes. The company's services include supply chain services, software services and prescription management, intended for the well-being of animals and those who care for them drives to advance the world of veterinary medicine.

Sesh

Seed Round in 2020
Sesh Therapy Incorporated is a mental health company that delivers online group support through its mobile application. Founded in 2020 and headquartered in San Francisco, California, Sesh provides a range of sessions led by qualified mental health professionals, making mental healthcare more accessible and affordable compared to traditional therapy appointments. The platform aims to connect individuals seeking support in a collaborative environment, enhancing the overall mental health experience.

FidoCure

Series A in 2020
The One Health Company is a social impact company that brings precision medicine, used in humans, to dogs with cancer. It started by offering dogs with cancer access to cutting edge human clinical trials at no cost. Then, they created FidoCure directly for veterinarians and pet parents to offer treatment options to more dogs across the country. The company built partnerships with the world's top cancer researchers and a network of 111 of the best veterinary hospitals.

Thirty Madison

Series B in 2020
Thirty Madison, Inc. is a digital health company based in Astoria, New York, focused on providing specialized care for chronic conditions through its web-based platforms. Founded in 2016, the company operates several condition-specific brands: Keeps, which offers a subscription service for men's hair loss prevention medications; Cove, which provides online consultations and prescriptions for migraine treatment; and Evens, designed to manage acid reflux. By offering these tailored services, Thirty Madison aims to increase access to affordable healthcare solutions, addressing the unique needs of patients suffering from these conditions.

Keeps

Series B in 2020
2 out of 3 men will start to lose their hair by the age of 35 - but the earlier you take action, the more hair you keep. Keeps is a full-service healthcare company focused exclusively on helping men keep their hair. From expert diagnosis to affordable treatment, patient support to education, Keeps provides a regimen specific to each customer's condition through a seamless digital experience, allowing men to manage hair loss from start to finish. Keeps’ licensed physicians review each customer's information in order to identify and prescribe a unique treatment plan of FDA-approved products, and we sell them at half the price customers would pay at their local pharmacy. With Keeps, customers receive exactly what they need, and nothing they don’t. Keeps is the first brand from Thirty Madison, which is rebuilding the healthcare experience for the modern consumer.

Foresight Mental Health

Series A in 2020
Foresight Mental Health is a technology-enabled company focused on providing comprehensive psychiatry and therapy services. It employs a team of psychiatrists, therapists, and psychiatric nurse practitioners who deliver treatment directly to patients in its clinics. Foresight aims to transform mental healthcare by integrating advanced technology developed by its software and biomedical engineers with clinical practice. The company offers a wide range of mental health treatments and wellness services, utilizing patient profiles that incorporate scientific research, genetic information, and detailed assessments of symptoms and brain chemistry. This holistic approach is designed to enhance patient outcomes, promoting improved mental health and overall well-being.

FOLX

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

ByHeart

Series A in 2020
ByHeart, Inc. is an infant nutrition company that develops a range of nutritional food products for infants and babies, focusing on immune, microbiome, cognitive, and digestive health. Founded in 2016 and headquartered in New York, the company operates facilities in Pennsylvania. ByHeart emphasizes the use of hand-picked ingredients and small-batch blending to create formulas that reflect the latest in nutrition science and breastmilk research. Their products are designed to support babies' health and provide parents with peace of mind, offering choices that help establish a strong foundation for future well-being.

Iora Health

Series F in 2020
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

Umbulizer

Pre Seed Round in 2020
Manufacturer of low-cost and portable breathing devices designed to reduce patient fatalities in resource-limited settings. The company's devices are simple to operate, portable, wirelessly monitored products that can provide continuous ventilation to patients, enabling medical practitioners to minimize the deaths of patients.

OM1

Series C in 2019
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Nomad Health

Series C in 2019
Nomad Health, Inc. operates an online marketplace that connects healthcare professionals with freelance and permanent job opportunities in the United States. Founded in 2015 and based in New York, the platform allows doctors and nurses to search for positions by various criteria, including location and pay rate. By streamlining the healthcare staffing process, Nomad Health aims to simplify job searches for medical professionals and facilitate the hiring needs of healthcare facilities. This modern technology platform addresses the complexities of traditional healthcare staffing, promoting efficiency and accessibility in the job market.

Ajax Health

Series C in 2019
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.

Quartet Health

Series D in 2019
Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the company partners with health plans and health systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. Quartet's platform facilitates access to suitable mental health care tailored to individual preferences and clinical needs, ensuring that care is compatible with patients' insurance plans. By connecting physicians, mental health providers, and insurance companies, Quartet seeks to improve the overall health of patients while also reducing healthcare costs.

Ajax Health

Series C in 2019
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.

Africa Healthcare Network

Series A in 2019
Africa Healthcare Network (AHN) has pioneered the first dialysis chain in Sub-Saharan Africa, aimed at delivering affordable, high-quality dialysis services for patients suffering from Acute Kidney Injury and End-Stage Renal Disease. In a region where existing facilities are limited and often charge exorbitant fees, AHN addresses the critical shortage of accessible dialysis care. The organization leverages its technical expertise and practical experience to establish well-equipped centers, while also focusing on training healthcare professionals to enhance service delivery. As Chronic Kidney Disease and related health issues rise due to urbanization and lifestyle changes, AHN's model prioritizes operational efficiency and cost-effective sourcing of medical supplies, thereby reducing treatment costs for patients. Operating in Rwanda, Tanzania, and Kenya, AHN is committed to increasing access to life-saving dialysis care, ultimately improving patient outcomes while ensuring financial sustainability.

KenSci

Series B in 2019
KenSci's machine learning powered risk prediction platform helps healthcare providers and payers intervene early by identifying clinical, financial and operational risk to save costs and lives. KenSci's platform is engineered to ingest, transform and integrate healthcare data across clinical, claims, and patient-generated sources. With a library of pre-built models and modular solutions, KenSci's machine learning platform to integrates into existing workflows allowing health systems to better identify utilization, variation and improve hospital operations. With Explainable AI models for healthcare, KenSci is making risk-based prediction more efficient and accountable.

Wellthy

Series A in 2019
Wellthy, Inc. is a family care concierge service based in New York, established in 2014. The company specializes in assisting individuals and families in managing the complexities of care for chronically ill, aging, or disabled loved ones. Wellthy connects families with dedicated Care Coordinators who help navigate the logistical and administrative tasks associated with caregiving. Their platform enables families to track appointments, organize tasks, store important documents, and maintain communication. Wellthy addresses various needs beyond medical care, including legal, financial, housing, and emotional support. The service is designed to alleviate the burden of caregiving by taking on tasks such as making calls, scheduling appointments, and managing paperwork. Additionally, Wellthy partners with employers to offer a compassionate and scalable solution to support families dealing with aging-related issues, childcare, special needs, and other ongoing care challenges.

Ajax Health

Series B in 2018
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.

OM1

Series B in 2018
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Iora Health

Series E in 2018
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

Nomad Health

Series B in 2018
Nomad Health, Inc. operates an online marketplace that connects healthcare professionals with freelance and permanent job opportunities in the United States. Founded in 2015 and based in New York, the platform allows doctors and nurses to search for positions by various criteria, including location and pay rate. By streamlining the healthcare staffing process, Nomad Health aims to simplify job searches for medical professionals and facilitate the hiring needs of healthcare facilities. This modern technology platform addresses the complexities of traditional healthcare staffing, promoting efficiency and accessibility in the job market.

Quartet Health

Series C in 2018
Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the company partners with health plans and health systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. Quartet's platform facilitates access to suitable mental health care tailored to individual preferences and clinical needs, ensuring that care is compatible with patients' insurance plans. By connecting physicians, mental health providers, and insurance companies, Quartet seeks to improve the overall health of patients while also reducing healthcare costs.

YourBio Health

Series C in 2016
YourBio Health is focused on transforming the blood collection process by developing innovative products that simplify diagnostic testing for patients. The company's flagship technology, Touch Activated Phlebotomy (TAP), allows users to collect their own blood painlessly and easily through a single-step process. This advancement not only enhances patient autonomy but also facilitates access to critical diagnostic information, thereby improving healthcare delivery. The On Vivo platform further supports safe and efficient diagnostic testing, making it accessible to a wider audience. By integrating TAP technology with various diagnostic assays and analytical systems, YourBio Health aims to enhance the overall experience for both patients and clinicians in the healthcare landscape. Founded in 2007 and based in Medford, Massachusetts, the company is committed to advancing informed healthcare participation and outcomes.

Africa Healthcare Network

Venture Round in 2016
Africa Healthcare Network (AHN) has pioneered the first dialysis chain in Sub-Saharan Africa, aimed at delivering affordable, high-quality dialysis services for patients suffering from Acute Kidney Injury and End-Stage Renal Disease. In a region where existing facilities are limited and often charge exorbitant fees, AHN addresses the critical shortage of accessible dialysis care. The organization leverages its technical expertise and practical experience to establish well-equipped centers, while also focusing on training healthcare professionals to enhance service delivery. As Chronic Kidney Disease and related health issues rise due to urbanization and lifestyle changes, AHN's model prioritizes operational efficiency and cost-effective sourcing of medical supplies, thereby reducing treatment costs for patients. Operating in Rwanda, Tanzania, and Kenya, AHN is committed to increasing access to life-saving dialysis care, ultimately improving patient outcomes while ensuring financial sustainability.

Iora Health

Series D in 2016
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

US HealthVest

Series B in 2016
US HealthVest is an innovative behavioral healthcare firm that has redefined the psychiatric hospital space. De novo strategies and acquisitions of operating facilities with unrealized potential are the core of the US HealthVest business model. Each facility is structured to offer multiple service lines in order to serve the needs of specific patient population groups. The senior management team of US HealthVest has successfully built psychiatric hospital businesses which were acquired by public companies. Ascend Health was founded by Richard Kresch, M.D. in 2005 and was one of the largest private psychiatric hospital providers with nine freestanding facilities and nearly 900 beds. Ascend Health was sold to Universal Health Services (NYSE: UHS) in 2012. The predecessor company, Heartland Health Developments, also focused on psychiatric care and was sold to Psychiatric Solutions in 2004.

Quartet Health

Series B in 2016
Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the company partners with health plans and health systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. Quartet's platform facilitates access to suitable mental health care tailored to individual preferences and clinical needs, ensuring that care is compatible with patients' insurance plans. By connecting physicians, mental health providers, and insurance companies, Quartet seeks to improve the overall health of patients while also reducing healthcare costs.

Arsenal Medical

Venture Round in 2015
Arsenal Medical, Inc. is a platform technology company based in Watertown, Massachusetts, that specializes in developing polymer-based foams and fibers for the treatment of vascular diseases. Founded in 2005, the company focuses on creating in-situ forming foams to address acute hemorrhage and other critical medical conditions, including vascular injury and repair. Arsenal Medical's proprietary technologies include its therapeutic foam and AxioCore, a novel nanofiber technology designed to enhance cell integration and tissue regeneration, allowing for the controlled delivery of various biologics and therapeutics. The company is advancing multiple preclinical programs and is supported by venture funding as well as grants from prominent organizations, including the Department of Defense and the Bill & Melinda Gates Foundation.

Quartet Health

Series A in 2015
Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the company partners with health plans and health systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. Quartet's platform facilitates access to suitable mental health care tailored to individual preferences and clinical needs, ensuring that care is compatible with patients' insurance plans. By connecting physicians, mental health providers, and insurance companies, Quartet seeks to improve the overall health of patients while also reducing healthcare costs.

Iora Health

Series C in 2015
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

First Opinion

Series A in 2014
First Opinion, Inc. is a healthcare technology company based in San Francisco, California, founded in 2013. It has developed a smartphone application that connects mothers with healthcare professionals, specifically doctors who are also mothers, through a messaging platform. This service addresses a range of topics including illness, injury, pregnancy, child development, nutrition, lactation, and sleep training. The application allows users to receive immediate responses to their health-related inquiries, available 24 hours a day. While users can ask questions for free, there is an option to upgrade for additional treatment services if needed.

YourBio Health

Series B in 2014
YourBio Health is focused on transforming the blood collection process by developing innovative products that simplify diagnostic testing for patients. The company's flagship technology, Touch Activated Phlebotomy (TAP), allows users to collect their own blood painlessly and easily through a single-step process. This advancement not only enhances patient autonomy but also facilitates access to critical diagnostic information, thereby improving healthcare delivery. The On Vivo platform further supports safe and efficient diagnostic testing, making it accessible to a wider audience. By integrating TAP technology with various diagnostic assays and analytical systems, YourBio Health aims to enhance the overall experience for both patients and clinicians in the healthcare landscape. Founded in 2007 and based in Medford, Massachusetts, the company is committed to advancing informed healthcare participation and outcomes.

Strata Health

Venture Round in 2014
Strata Health leverages technology to achieve dramatic patient flow improvement within health systems. Our clients say they’ve entrusted us with the job of creating patient flow solutions that achieve real and dramatic benefits for patients, their families and the world’s devoted front line caregivers. Operational in Canada and the UK, Strata Health is a privately held Canadian corporation. It is comprised of professionals with empathy for those who need care and intense respect for those who devote themselves to caring for others.

NextCODE Health

Series A in 2013
NextCODE Health LLC is a clinical diagnostics company specializing in sequence-based genomics. It offers a platform that assists healthcare professionals in obtaining clinical insights for rapid disease diagnosis. The company provides a range of services, including data analysis, genome interpretation, data mining, and sequencing services, both clinical and non-clinical. Founded on technology developed at deCODE genetics over 16 years, NextCODE focuses on integrating genome sequence data into patient care. Based in Cambridge, Massachusetts, the company was acquired by WuXi PharmaTech in 2015 and underwent a rebranding to Genuity Science in 2020. Through its innovative solutions, NextCODE aims to enhance the speed and accuracy of identifying genetic causes of diseases.

NextCODE Health

Series A in 2013
NextCODE Health LLC is a clinical diagnostics company specializing in sequence-based genomics. It offers a platform that assists healthcare professionals in obtaining clinical insights for rapid disease diagnosis. The company provides a range of services, including data analysis, genome interpretation, data mining, and sequencing services, both clinical and non-clinical. Founded on technology developed at deCODE genetics over 16 years, NextCODE focuses on integrating genome sequence data into patient care. Based in Cambridge, Massachusetts, the company was acquired by WuXi PharmaTech in 2015 and underwent a rebranding to Genuity Science in 2020. Through its innovative solutions, NextCODE aims to enhance the speed and accuracy of identifying genetic causes of diseases.

Iora Health

Series B in 2013
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, specializing in primary care services across the United States. Founded in 2010, the company is committed to overcoming the barriers typically present in the healthcare system by offering personalized care for each patient. Each individual is assigned a dedicated personal physician and health coach, who maintain regular communication through various channels, including email, text, and video, in addition to in-person consultations. Iora Health employs a team-based approach that includes a doctor or nurse practitioner, nurse, behavioral health specialist, and health coach, all supported by a proprietary technology platform for effective population health management. The organization also provides educational programs, such as group visits, to assist patients in achieving their health goals and managing their overall well-being.

US HealthVest

Series A in 2013
US HealthVest is an innovative behavioral healthcare firm that has redefined the psychiatric hospital space. De novo strategies and acquisitions of operating facilities with unrealized potential are the core of the US HealthVest business model. Each facility is structured to offer multiple service lines in order to serve the needs of specific patient population groups. The senior management team of US HealthVest has successfully built psychiatric hospital businesses which were acquired by public companies. Ascend Health was founded by Richard Kresch, M.D. in 2005 and was one of the largest private psychiatric hospital providers with nine freestanding facilities and nearly 900 beds. Ascend Health was sold to Universal Health Services (NYSE: UHS) in 2012. The predecessor company, Heartland Health Developments, also focused on psychiatric care and was sold to Psychiatric Solutions in 2004.

YourBio Health

Series A in 2012
YourBio Health is focused on transforming the blood collection process by developing innovative products that simplify diagnostic testing for patients. The company's flagship technology, Touch Activated Phlebotomy (TAP), allows users to collect their own blood painlessly and easily through a single-step process. This advancement not only enhances patient autonomy but also facilitates access to critical diagnostic information, thereby improving healthcare delivery. The On Vivo platform further supports safe and efficient diagnostic testing, making it accessible to a wider audience. By integrating TAP technology with various diagnostic assays and analytical systems, YourBio Health aims to enhance the overall experience for both patients and clinicians in the healthcare landscape. Founded in 2007 and based in Medford, Massachusetts, the company is committed to advancing informed healthcare participation and outcomes.

Arsenal Medical

Debt Financing in 2011
Arsenal Medical, Inc. is a platform technology company based in Watertown, Massachusetts, that specializes in developing polymer-based foams and fibers for the treatment of vascular diseases. Founded in 2005, the company focuses on creating in-situ forming foams to address acute hemorrhage and other critical medical conditions, including vascular injury and repair. Arsenal Medical's proprietary technologies include its therapeutic foam and AxioCore, a novel nanofiber technology designed to enhance cell integration and tissue regeneration, allowing for the controlled delivery of various biologics and therapeutics. The company is advancing multiple preclinical programs and is supported by venture funding as well as grants from prominent organizations, including the Department of Defense and the Bill & Melinda Gates Foundation.

YourBio Health

Series A in 2011
YourBio Health is focused on transforming the blood collection process by developing innovative products that simplify diagnostic testing for patients. The company's flagship technology, Touch Activated Phlebotomy (TAP), allows users to collect their own blood painlessly and easily through a single-step process. This advancement not only enhances patient autonomy but also facilitates access to critical diagnostic information, thereby improving healthcare delivery. The On Vivo platform further supports safe and efficient diagnostic testing, making it accessible to a wider audience. By integrating TAP technology with various diagnostic assays and analytical systems, YourBio Health aims to enhance the overall experience for both patients and clinicians in the healthcare landscape. Founded in 2007 and based in Medford, Massachusetts, the company is committed to advancing informed healthcare participation and outcomes.

Phreesia

Series D in 2010
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

Respicardia

Series C in 2010
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.

Phreesia

Series D in 2010
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

Arsenal Medical

Venture Round in 2010
Arsenal Medical, Inc. is a platform technology company based in Watertown, Massachusetts, that specializes in developing polymer-based foams and fibers for the treatment of vascular diseases. Founded in 2005, the company focuses on creating in-situ forming foams to address acute hemorrhage and other critical medical conditions, including vascular injury and repair. Arsenal Medical's proprietary technologies include its therapeutic foam and AxioCore, a novel nanofiber technology designed to enhance cell integration and tissue regeneration, allowing for the controlled delivery of various biologics and therapeutics. The company is advancing multiple preclinical programs and is supported by venture funding as well as grants from prominent organizations, including the Department of Defense and the Bill & Melinda Gates Foundation.

Phytel

Venture Round in 2010
Phytel, Inc. is a provider of population health management software solutions aimed at healthcare organizations, facilitating coordinated care for patients. Established in 1996 and based in Dallas, Texas, Phytel serves a diverse range of clients, including accountable care organizations, physician practices, hospitals, health systems, integrated delivery networks, and community health centers. The company's offerings include disease management and preventive care protocols that help identify and notify patients who are not compliant with their healthcare plans. Additionally, Phytel develops and maintains essential prescription, laboratory, and clinical data to support health and disease management. The company also provides systems integration, application development, and reporting services to enhance healthcare delivery and improve patient outcomes. As of May 2015, Phytel operates as a subsidiary of International Business Machines Corporation.

MicroCHIPS

Venture Round in 2010
MicroCHIPS Biotech, Inc. specializes in developing a microchip-based implant designed for drug delivery applications across various therapeutic areas, including osteoporosis, diabetes, multiple sclerosis, women’s contraception, and pain management. This innovative implant can store and release precise doses of medication over extended periods, offering an alternative to traditional therapies that rely on frequent injections. The implant is surgically placed under the skin during a minimally invasive procedure and can be wirelessly activated or deactivated by healthcare providers or patients. Additionally, the device allows for real-time adjustments to the drug dosage and frequency, catering to the specific needs of each patient. Established in 1999 and headquartered in Lexington, Massachusetts, MicroCHIPS operates as a subsidiary of Daré Bioscience, Inc.

Free & Clear

Venture Round in 2010
Free & Clear, Inc. specializes in providing phone-based tobacco treatment services aimed at employers, health plans, and government agencies. The company offers a comprehensive tobacco cessation program, including Quit For Life, which assists employees and members in quitting smoking and using smokeless tobacco. Additionally, Free & Clear addresses broader health risks linked to chronic diseases through its Mind & Body Program, which focuses on behavior change and encourages individuals to maintain a healthy weight. By delivering these clinically proven interventions, Free & Clear aims to support a healthier workforce and reduce tobacco-related health issues.

Phreesia

Series C in 2009
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

Vyne

Venture Round in 2009
Vyne is a healthcare technology company based in Dunwoody, Georgia, with additional offices in Knoxville, Tennessee. The company operates an integrated platform that facilitates the secure exchange of protected health information and management of healthcare communications among patients, providers, payers, and partners. Vyne's platform enables the electronic capture, storage, and submission of various forms of healthcare data, including voice, fax, image, and electronic documents. This capability allows medical and dental providers, as well as payers, to effectively manage critical information, address gaps in documentation, and enhance the continuum of care through accessible patient records. Vyne Medical and NEA Powered by Vyne are the primary brands under the Vyne umbrella, focusing on secure health information exchange solutions.

CodeRyte

Series D in 2008
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.

Respicardia

Series B in 2008
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.

Imprivata

Series C in 2008
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

HealthCentral

Post in 2008
HealthCentral operates a network of over 30 websites focused on various health conditions, wellness, and general health topics, including allergy, bipolar disorder, cholesterol, and high blood pressure. These platforms offer users access to medical news, videos, and community interactions, as well as reputable resources like Harvard Health Publications. In addition to its online presence, HealthCentral produces the nationally syndicated television show "Medical Breakthroughs with Dr. Dean Edell." Founded in 1999 and based in Arlington, Virginia, HealthCentral was originally known as ChoiceMedia, Inc. The company has undergone significant investment changes since its acquisition in 2005 by various firms, including Polaris Venture Partners and The Carlyle Group, with a notable minority stake acquired by IAC. HealthCentral competes with other health information providers such as WebMD and RevolutionHealth.

Arsenal Medical

Series B in 2007
Arsenal Medical, Inc. is a platform technology company based in Watertown, Massachusetts, that specializes in developing polymer-based foams and fibers for the treatment of vascular diseases. Founded in 2005, the company focuses on creating in-situ forming foams to address acute hemorrhage and other critical medical conditions, including vascular injury and repair. Arsenal Medical's proprietary technologies include its therapeutic foam and AxioCore, a novel nanofiber technology designed to enhance cell integration and tissue regeneration, allowing for the controlled delivery of various biologics and therapeutics. The company is advancing multiple preclinical programs and is supported by venture funding as well as grants from prominent organizations, including the Department of Defense and the Bill & Melinda Gates Foundation.

Phreesia

Series B in 2007
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

Solace Pharmaceuticals

Series A in 2007
Solace Pharmaceuticals, a Boston based drug company focused on therapeutics for chronic pain.

Ascend Health

Series B in 2007
Ascend Health Corporation is a behavioral healthcare provider, offering a full range of inpatient and day hospital services to children, adolescents, adults and seniors. They focus on personal choice and specialized care. Their facilities provide high quality care by working closely to integrate their services with the healthcare system in each local community.

CodeRyte

Series C in 2006
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.

Imprivata

Series B in 2006
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

Imprivata

Series A in 2005
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

Life Line Screening

Private Equity Round in 2005
Life Line Screening of America, Ltd. provides community-based preventive health screening services in the United States and the United Kingdom. The company offers ultrasound, finger-stick blood, and limited electrocardiograph screenings. It provides screenings for stroke/carotid artery disease, abdominal aortic aneurysm, stroke/atrial fibrillation, peripheral arterial disease, heart disease risk, osteoporosis risk, elevated C-reactive protein, high cholesterol, type 2 diabetes, elevated liver enzymes, and chronic kidney disease. The company was founded in 1993 and is headquartered in Austin, Texas.

The Center from Health Promotion

Venture Round in 2003
The Center for Health Promotion Inc. delivers tobacco cessation and weight management services to customers nationwide. As an operating unit of Group Health Cooperative (Seattle) for almost 20 years, CHP developed the telephone-based Free & Clear program and established itself a national leader in tobacco cessation. Today CHP continues to deliver tobacco cessation services through health plans, businesses and labor organizations around the country. CHP also provides phone-based tobacco cessation services to residents of Georgia, Maine, Minnesota, Oklahoma, Oregon, Utah, Washington and Wisconsin through contracts with state agencies or coalitions. The company is actively engaged in research trials with major research centers including The Stanford Research Institute in Menlo Park, Calif., the Center for Health Research in Portland, Ore., and the Fred Hutchison Cancer Research Center and Group Health's Center for Health Studies, both in Seattle. This active research is undertaken to help improve CHP's services to smokers and increase scientific understanding of this key health issue.

Imprivata

Series A in 2002
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

Sentillion

Series C in 2001
Sentillion, Inc. specializes in identity and access management technology solutions tailored for caregivers in hospitals and healthcare organizations across North America and the United Kingdom. The company's offerings include expreSSO, which facilitates transparent single sign-on within existing workflows, and Bridges, a tool for interfacing with various applications. Additionally, proVision allows for the alteration, disabling, and termination of access to systems and applications. Sentillion also provides Vergence, which integrates single sign-on and authentication services for clinical workstations, enabling seamless navigation of clinical and business applications. The company's vThere solution assists in managing clinicians and staff, while IdMPOWER streamlines the incorporation of applications and information systems. In addition to technology solutions, Sentillion offers comprehensive implementation services, including project planning and training, as well as technical support services to assist clients with troubleshooting and operational needs. Founded in 1998, Sentillion is headquartered in Andover, Massachusetts.

Sentillion

Series B in 2000
Sentillion, Inc. specializes in identity and access management technology solutions tailored for caregivers in hospitals and healthcare organizations across North America and the United Kingdom. The company's offerings include expreSSO, which facilitates transparent single sign-on within existing workflows, and Bridges, a tool for interfacing with various applications. Additionally, proVision allows for the alteration, disabling, and termination of access to systems and applications. Sentillion also provides Vergence, which integrates single sign-on and authentication services for clinical workstations, enabling seamless navigation of clinical and business applications. The company's vThere solution assists in managing clinicians and staff, while IdMPOWER streamlines the incorporation of applications and information systems. In addition to technology solutions, Sentillion offers comprehensive implementation services, including project planning and training, as well as technical support services to assist clients with troubleshooting and operational needs. Founded in 1998, Sentillion is headquartered in Andover, Massachusetts.

Esurg.com

Series B in 2000
Esurg.com, the most comprehensive and trusted online source for medical, surgical and pharmaceutical supplies and information. They designed Their Web site for the growing number of physician practices and clinics working outside traditional hospital settings — to give them an edge in the increasingly complex business of medicine.

Accordant Health Services

Venture Round in 2000
Accordant provides its program members with healthcare advice. The service focuses on delivering support for patients with rare, chronic diseases. Its care management solutions comprise of tools and resources of professionals in the healthcare sector. The service also delivers care management services for rare diseases which include health plans, employers, and third party administrators. Accordant is a subsidiary of CVS Caremark. It was founded by Steve Schelhammer and is headquartered in Greensboro, North Carolina.

Esurg.com

Series A in 1999
Esurg.com, the most comprehensive and trusted online source for medical, surgical and pharmaceutical supplies and information. They designed Their Web site for the growing number of physician practices and clinics working outside traditional hospital settings — to give them an edge in the increasingly complex business of medicine.

Sentillion

Series A in 1999
Sentillion, Inc. specializes in identity and access management technology solutions tailored for caregivers in hospitals and healthcare organizations across North America and the United Kingdom. The company's offerings include expreSSO, which facilitates transparent single sign-on within existing workflows, and Bridges, a tool for interfacing with various applications. Additionally, proVision allows for the alteration, disabling, and termination of access to systems and applications. Sentillion also provides Vergence, which integrates single sign-on and authentication services for clinical workstations, enabling seamless navigation of clinical and business applications. The company's vThere solution assists in managing clinicians and staff, while IdMPOWER streamlines the incorporation of applications and information systems. In addition to technology solutions, Sentillion offers comprehensive implementation services, including project planning and training, as well as technical support services to assist clients with troubleshooting and operational needs. Founded in 1998, Sentillion is headquartered in Andover, Massachusetts.

Remedy Health Media

Seed Round in 1997
Remedy Health Media is an operator of a digital health platform intended to provide health-related information that produces, publishes, and distributes health magazines to consumers and caregivers. It offers content, tools, and real stories related to consumer health and wellness through the development of authentic communities of health information seekers who can interact and learn from a relatable physician, pharmacist, public health, and patient experts that enable the customers to make informed choices about their health and well-being. The company's mission is to empower patients and caregivers with the information and applications needed to efficiently navigate the healthcare landscape and as a result, to permit better health outcomes through the use of its products and services. Remedy Health Media was established in 1994 and is headquartered in New York.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.